Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

193

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03BA02	PULMICORT	B	Budesonide - 0.5mg/ml	0.5mg/ml	Inhalation suspension for nebuliser	2,015,764 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
A05AA04	OCALIVA	B	Obeticholic acid - 5mg	5mg	Tablet, film coated	224,503,943 L.L
A10BD15	XIGDUO XR	B	Metformin HCl XR - 1000mg, Dapagliflozin - 10mg		Tablet	3,006,579 L.L
B01AC27	UPTRAVI	B	Selexipag - 400mcg	400mcg	Tablet, film coated	242,569,645 L.L
G03FB01	PROGYLUTON	B	Norgestrel - 0.5mg (tablet 2), Estradiol valerate - 2mg (tablet 1, tablet 2)		Tablet	193,513 L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	13,942,481 L.L
M03AC11	NIMBEX	B	Cisatracurium (besylate) - 20mg/10ml	20mg/10ml	Injectable solution	2,010,388 L.L
N06BA04	RITALIN	B	Methylphenidate HCl - 10mg	10mg	Tablet	376,276 L.L
A01AD11	PYRALVEX	B	Salicylic acid - 0.01g/ml, Rhubarb (Anthraquinone Glycosides) - 0.05g/ml		Solution	327,898 L.L
B01AC27	UPTRAVI	B	Selexipag - 600mcg	600mcg	Tablet, film coated	242,569,645 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g		Cream	1,064,323 L.L
J01AA04	TETRALYSAL	B	Lymecycline - 300mg	300mg	Capsule	796,899 L.L
J05AB01	ZOVIRAX	B	Aciclovir - 200mg/5ml	200mg/5ml	Suspension	487,815 L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	13,942,481 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 3%	3%	Solution	163,949 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 27mg	27mg	Tablet, extended release	4,393,021 L.L
A06AB02	DULCOLAX	B	Bisacodyl - 5mg	5mg	Tablet, sugar coated	520,067 L.L
B01AC27	UPTRAVI	B	Selexipag - 800mcg	800mcg	Tablet, film coated	242,569,645 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 1g	1g	Tablet, effervescent	129,009 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 5mg	5mg	Tablet, dispersible	2,607,054 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 36mg	36mg	Tablet, extended release	4,393,021 L.L
C02KX04	OPSUMIT	B	Macitentan - 10mg	10mg	Tablet, film coated	L.L
A02AC10	RENNIE	B	Magnesium carbonate - 80mg, Calcium carbonate - 680mg		Tablet, chewable	240,548 L.L
A06AB02	DULCOLAX	B	Bisacodyl - 5mg	5mg	Tablet, sugar coated	219,046 L.L
B01AC27	UPTRAVI	B	Selexipag - 1000mcg	1000mcg	Tablet, film coated	242,569,645 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g		Gauze	1,463,444 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	68,645,618 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 5mg	5mg	Tablet, dispersible	2,607,054 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 54mg	54mg	Tablet, extended release	6,049,979 L.L

...

193